Protect Your Bank Account Before It’s Too Late

For months I’ve been warning about the federal government’s terrifying new program to control every American’s bank account. It gives them the power to monitor every single transaction …

Stop right now and do these 3 things to protect yourself

Christopher Hix Biography and Net Worth

CFO of Enovis

Christopher M. Hix serves as Chief Financial Officer, Executive Vice President - Finance of the Company. Mr. Hix has been Executive Vice President, Finance, Chief Financial Officer since December 2019 and prior to such position served as Senior Vice President, Finance, since July 2016. Prior to joining Colfax, Mr. Hix was the Chief Financial Officer of OM Group, Inc., a global, publicly-listed diversified industrial company. Mr. Hix served within OM Group from 2012 until the company’s acquisition in late 2015. Previously, Mr. Hix was the Chief Financial Officer of Robbins & Myers, a diversified industrial company, from 2006 to 2011. Prior to that, Mr. Hix spent 13 years in a variety of positions with increasing responsibility in operating, financial and strategic roles within Roper Industries, a global, diversified industrial and technology company that underwent rapid growth and transition from private to public ownership during his tenure. Mr. Hix earned his M.B.A. from St. Mary’s College of California and his B.S. in Business Administration from the University of Southern California.

What is Christopher M. Hix's net worth?: The estimated net worth of Christopher M. Hix is at least $1.87 million as of March 4th, 2024. Mr. Hix owns 33,863 shares of Enovis stock worth more than $1,870,253 as of April 27th. This net worth estimate does not reflect any other investments that Mr. Hix may own. Learn More about Christopher M. Hix's net worth.
How do I contact Christopher M. Hix?: The corporate mailing address for Mr. Hix and other Enovis executives is 2711 Centerville Road Suite 400, Wilmington DE, 19808. Enovis can also be reached via phone at 302-252-9160 and via email at [email protected]. Learn More on Christopher M. Hix's contact information.
Has Christopher M. Hix been buying or selling shares of Enovis?: Christopher M. Hix has not been actively trading shares of Enovis in the last ninety days. Most recently, Christopher M. Hix sold 1,367 shares of the business's stock in a transaction on Wednesday, December 14th. The shares were sold at an average price of $55.28, for a transaction totalling $75,567.76. Following the completion of the sale, the chief financial officer now directly owns 44,605 shares of the company's stock, valued at $2,465,764.40. Learn More on Christopher M. Hix's trading history.
Who are Enovis' active insiders?: Enovis' insider roster includes Benjamin Berry (CFO), Christopher Hix (CFO), John Kleckner (Insider), Patricia Lang (SVP), A. Perfall (Director), Daniel Pryor (EVP), Brady Shirley (COO), Bradley Tandy (SVP), Matthew Trerotola (CEO), and Rajiv Vinnakota (Director). Learn More on Enovis' active insiders.
Are insiders buying or selling shares of Enovis?: During the last year, insiders at the sold shares 4 times. They sold a total of 2,282 shares worth more than $129,436.69. The most recent insider tranaction occured on August, 7th when insider John Kleckner sold 174 shares worth more than $10,297.32. Insiders at Enovis own 2.4% of the company. Learn More about insider trades at Enovis.
Information on this page was last updated on 8/7/2023.

Christopher M. Hix Insider Trading History at Enovis

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
12/14/2022	Sell	1,367	$55.28	$75,567.76	44,605

Christopher M. Hix Buying and Selling Activity at Enovis

Enovis Company Overview

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. The company's Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware.

Today's Range

Now: $55.23

$54.82

$55.53

50 Day Range

MA: $59.95

$55.07

$63.80

2 Week Range

Now: $55.23

$43.04

$66.14

Volume

304,173 shs

Average Volume

455,590 shs

Market Capitalization

$3.03 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.97